News
FDA approves flu vaccine for adults 65 years and older
The first adjuvanted quadrivalent influenza vaccine has been approved to help protect adults 65 years and older against seasonal influenza.
Fluad Quadrivalent (aQIV) utilises the...
Breakthrough status for Padcev in combination with Keytruda
Padcev in combination with Keytruda has been granted Breakthrough Therapy status by the FDA for the treatment of patients in first-line advanced bladder cancer.
The...
US closer to commercialising first gene therapy for haemophilia
The Biologics License Application for BioMarin Pharmaceutical’s investigational AAV5 gene therapy, valoctocogene roxaparvovec, for adults with haemophilia A is closer to approval in the...
